Literature DB >> 7829215

International renal-cell cancer study. I. Tobacco use.

J K McLaughlin1, P Lindblad, A Mellemgaard, M McCredie, J S Mandel, B Schlehofer, W Pommer, H O Adami.   

Abstract

The relationship between renal-cell cancer (RCC) and tobacco use was investigated in an international, multicenter, population-based case-control study. Coordinated studies were conducted in Australia, Denmark, Germany, Sweden and the United States using a shared protocol and questionnaire. A total of 1,732 cases (1,050 men, 682 women) and 2,309 controls (1,429 men, 880 women) were interviewed for the study. No association was observed between risk and use of cigars, pipes or smokeless tobacco. A statistically significant association was observed for cigarette smoking, with current smokers having a 40% increase in risk [relative risk (RR) = 1.4, 95% confidence interval (CI) 1.2-1.7]. Risk increased with intensity (number of cigarettes) and duration (years smoked). Among current smokers the RR for pack-years rose from 1.1 (95% CI 0.8-1.5) for < 15.9 pack years to 2.0 (95% CI 1.6-2.7) for > 42 pack years (p for trend < 0.001). Long-term quitters (> 15 years) experienced a reduction in risk of about 15-25% relative to current smokers. Those who started smoking late (> 24 years of age) had about two-thirds the risk of those who started young (< or = 12 years of age). Overall, the findings of this pooled analysis confirm that cigarette smoking is a causal factor in the etiology of RCC.

Entities:  

Mesh:

Year:  1995        PMID: 7829215     DOI: 10.1002/ijc.2910600211

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer.

Authors:  Behfar Ehdaie; Helena Furberg; Emily Craig Zabor; A Ari Hakimi; Paul Russo
Journal:  J Urol       Date:  2013-09-07       Impact factor: 7.450

Review 2.  Systematic review of the relation between smokeless tobacco and cancer in Europe and North America.

Authors:  Peter N Lee; Jan Hamling
Journal:  BMC Med       Date:  2009-07-29       Impact factor: 8.775

3.  A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma.

Authors:  Todd M Gibson; Stephanie J Weinstein; Susan T Mayne; Ruth M Pfeiffer; Jacob Selhub; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

Review 4.  Mitochondrial toxicity of tobacco smoke and air pollution.

Authors:  Jessica L Fetterman; Melissa J Sammy; Scott W Ballinger
Journal:  Toxicology       Date:  2017-08-22       Impact factor: 4.221

Review 5.  Risk factors, classification, and staging of renal cell cancer.

Authors:  Damian A Laber
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 6.  Lifestyle issues and genitourinary tumours.

Authors:  Frank Sommer; Theo Klotz; Bernd J Schmitz-Dräger
Journal:  World J Urol       Date:  2003-12-12       Impact factor: 4.226

7.  Renal cell carcinoma under 35 years of age: comparison of survival rates for symptomatic and asymptomatic patients.

Authors:  Vahudin Zugor; Swetlana Fridel; Berthold Lausen; Günter E Schott; Reinhard Kühn; Apostolos P Labanaris
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

8.  Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91.

Authors:  M McCredie; G J Macfarlane; J Stewart; M Coates
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

9.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

10.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.